Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia (Q34088976)

30 July 2017

Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia (English)

1 reference

30 July 2017

1 reference

3

Elai Davicioni

1 reference

30 July 2017

Erik S Knudsen

1

1 reference

30 July 2017

Adam Ertel

2

1 reference

30 July 2017

Jessica Kline

4

1 reference

30 July 2017

Gordon F Schwartz

5

1 reference

30 July 2017

Agnieszka K Witkiewicz

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

2 December 2011

1 reference

Breast Cancer Research and Treatment

30 July 2017

1 reference

30 July 2017

133

1 reference

30 July 2017

3

1 reference

30 July 2017

1009-1024

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-011-1894-3

30 July 2017

0 references

cites work

Ductal carcinoma in situ, complexities and challenges.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Local outcomes in ductal carcinoma in situ based on patient and tumor characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Biology of ductal carcinoma in situ classification based on biologic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Recent advances and current controversies in the management of DCIS of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Gene expression profiles of human breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Gene expression profiling of the tumor microenvironment during breast cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Molecular characterization of the tumor microenvironment in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Method for grading breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its impl

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Laser capture microdissection and advanced molecular analysis of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Identification of common differentially expressed genes in urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Identifying differentially expressed genes using false discovery rate controlling procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Filtering for increased power for microarray data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Significance analysis of microarrays applied to the ionizing radiation response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Classification of ductal carcinoma in situ by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

NCBI GEO: mining tens of millions of expression profiles--database and tools update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

ArrayExpress--a public repository for microarray gene expression data at the EBI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Epithelial-mesenchymal transition and tumour invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

A direct approach to false discovery rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1894-3

10.1007/S10549-011-1894-3

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference